The mental and behavioral mood of PD patients was evaluated using MDS-UPDRS I. There was no statistically significant difference between the GLP-1 agonists group compared to the control group which aligned with the previous systematic review made by Mulvaney et al. (2020). The gene discussed is GCG; the disease is Parkinson disease.